NW
BSX icon

NewEdge Wealth’s Boston Scientific BSX Stock Holding History

NewEdge Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
30,012
-26,089
-47% -$1.42M 0.01% 589
2026
Q1 		$3.52M Sell
56,101
-16,515
-23% -$1.32M 0.04% 290
2025
Q4 		$6.92M Buy
72,616
+9,917
+16% +$972K 0.08% 176
2025
Q3 		$6.2M Buy
62,699
+9,826
+19% +$1.02M 0.09% 175
2025
Q2 		$5.44M Buy
52,873
+5,569
+12% +$563K 0.09% 186
2025
Q1 		$4.77M Buy
47,304
+3,709
+9% +$373K 0.09% 195
2024
Q4 		$3.89M Sell
43,595
-540
-1% -$47.5K 0.07% 228
2024
Q3 		$3.7M Buy
44,135
+2,543
+6% +$200K 0.07% 250
2024
Q2 		$3.2M Sell
41,592
-2,068
-5% -$151K 0.07% 233
2024
Q1 		$3.14M Sell
43,660
-5,839
-12% -$375K 0.07% 235
2023
Q4 		$2.86M Sell
49,499
-2,717
-5% -$145K 0.07% 234
2023
Q3 		$2.76M Buy
52,216
+16,290
+45% +$854K 0.09% 202
2023
Q2 		$1.94M Buy
35,926
+31,539
+719% +$1.65M 0.06% 258
2023
Q1 		$219K Sell
4,387
-10,092
-70% -$476K 0.01% 567
2022
Q4 		$670K Buy
14,479
+5,601
+63% +$243K 0.03% 330
2022
Q3 		$344K Buy
+8,878
New +$356K 0.02% 401

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NewEdge Wealth's BSX Position: Q2 2026 in Review

NewEdge Wealth reduced its Boston Scientific (BSX) stake by 47% in Q2 2026, selling an estimated $1.42M and leaving 30,012 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #589.

NewEdge Wealth first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $6.92M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • NewEdge Wealth held 30,012 shares of Boston Scientific worth $1.28M as of Q2 2026.
  • NewEdge Wealth sold 26,089 Boston Scientific shares in Q2 2026, an estimated $1.42M.
  • Boston Scientific made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #589 holding.
  • NewEdge Wealth first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
  • NewEdge Wealth's Boston Scientific position peaked at $6.92M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.